Maggie Coffey is the former CEO of Tetragenetics. At the time of this interview, Tetragenetics' mission was to bring to the marketplace a new technology for the large-scale production of recombinant proteins for use in human and animal medicine.
Coffey received her undergraduate degree from Mount Holyoke, her MBA from Harvard Business School and her Doctorate in Veterinary Medicine from Cornell University.
The biotech company we started this year in January 2004, and it was funded--we started with $60,000, $20,000 came from shareholders, $20,000 came--this might be proprietary. Let's just not say the amounts of money. Let's go back. One-third came from shareholders, one-third came from one Board of...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
